Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × All Solid Tumors × Other solid neoplasm × Clear all

Phase

Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Solid Tumor 97 Advanced Solid Tumors 73 Solid Tumor 57 Mesothelioma 35 Mesothelioma, Malignant 34 Solid Tumors 33 Solid Tumor, Adult 22 Carcinoma, Non-Small-Cell Lung 21 Stomach Neoplasms 15 Ovarian Neoplasms 15 Esophageal Neoplasms 15 Colorectal Neoplasms 13 Carcinoma, Renal Cell 13 Melanoma 11 Endometrial Neoplasms 11 Neoplasm Metastasis 10 Uterine Cervical Neoplasms 9 Unspecified Adult Solid Tumor, Protocol Specific 9 Pancreatic Neoplasms 9 Neoplasms 9 Breast Neoplasms 9 Advanced Malignant Solid Tumor 9 Triple Negative Breast Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 8 Sarcoma 8 Lung Neoplasms 8 Advanced or Metastatic Solid Tumors 8 Malignant Solid Tumor 7 Carcinoma, Hepatocellular 7 Locally Advanced or Metastatic Solid Tumors 6

Interventions

Pharmaceutical Preparations 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01711398 2015-02-12

IP N02

Elro Pharma

Phase 1/2 Completed

Other solid neoplasm

All Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡